Dr. Alexander Titomirov, Ph D
Dr. Alexander Titomirov And His Company InforMax Inc. Were The Developers Of The Best Medical Search Engine (Www.PubMed.Org) As Well As Huge Contributors In Developing The National Center For Biotechnology Information (NCBI) Through A Contract With InforMax Inc. Which Lasted Over 10 Years. Dr. Titomirov Was Also A Founder Of Several Pioneering Technologies In The Field Of Cancer Treatment At The Russian Academy Of Sciences. He Discovered A Bacterial DHFR Genetic Effect That Prolonged The Lifespan In Irradiated Mice, And He Was One Of The Original Authors Of Stable Gene Transformation Of Skin Cells In Vivo, Using The Pioneering Technology “Shot Gun” With Tungsten Micro Projectiles. Titomirov Was Invited To Come To Work In The United States By James Watson – A Nobel Prize Winner And A Pioneer In Discovering The Structure Of DNA. He Worked At The National Institute Of Health (NIH) As Well As A Small Pharmaceutical Company Before Starting His Own Company InforMax, Inc.
In 1990. Dr. Titomirov Has Pioneered An Expert System Based On Modeling Of The Drug Discovery Process. InforMax Products Are Currently Sold To Over 65,000 Pharma And Biotech Companies Worldwide. InforMax Was Acquired By Invitrogen, A Major Bio-Science Company With $1.2 Billion In Annual Revenue, Headquartered In Carlsbad, California. In Addition, Titomirov Was One Of The Principal Developers Of The Software Infrastructure For The Human Genome Project, Founded By James Watson. Titomirov Was A Major Contributor To The Genomics Approach Of Drug Discovery – Which Is Demonstrated To Be One Of The Main Accelerators Of The Drug Discovery Process. Titomirov Earned His Ph.D. In 1986 At The Institute Of Cytology At The Russian Academy Of Sciences In St. Petersburg, Russia. Dr. Titomirov Pioneered The Field Of Transforming Animal Cells With Foreign DNA Which Had Led To Development Of Human DNA Vaccines And Was A Major Contribution To Human Genetics With More Than 50 Books Written Based On Dr. Titomirov’s Original Articles.
Click below for additional papers written in recent years by Dr. Alexander Titomirov :
1. http://www.rusmonaco.fr/index.php/item/2030
2. http://www.rusmonaco.fr/home/investitsii/item/2583-budushchee-dizajn-tekhnologii
3. http://www.rusmonaco.fr/home/investitsii/item/2584-belongs-to-design-and-technology
4. Page 134-135/136-137 : https://issuu.com/seatrial/docs/sea_trial_009_l
5. Page 120-121: https://issuu.com/seatrial/docs/sea_trial_008_m
6. Page 120-121: https://issuu.com/seatrial/docs/sea_trial_008_m/1?ff=true
7. http://www.rusmonaco.fr/home/investitsii/item/2298-uchenyj-izobretatel-biznesmen
8. Pages: 102-105: https://issuu.com/seatrial/docs/sea_trial_006_2017
9. Pages 104-105: https://issuu.com/seatrial/docs/sea_trial_007_2017/104
10. https://www.youtube.com/watch?v=GnFvkRgKN5o
11. https://www.youtube.com/watch?v=zWzKY3MJbxU&feature=youtu.be
12. http://www.rusmonaco.fr/index.php/item/650
13. http://www.rusmonaco.fr/index.php/item/699
14. http://www.rusmonaco.fr/index.php/item/684
1. http://www.rusmonaco.fr/index.php/item/2030
2. http://www.rusmonaco.fr/home/investitsii/item/2583-budushchee-dizajn-tekhnologii
3. http://www.rusmonaco.fr/home/investitsii/item/2584-belongs-to-design-and-technology
4. Page 134-135/136-137 : https://issuu.com/seatrial/docs/sea_trial_009_l
5. Page 120-121: https://issuu.com/seatrial/docs/sea_trial_008_m
6. Page 120-121: https://issuu.com/seatrial/docs/sea_trial_008_m/1?ff=true
7. http://www.rusmonaco.fr/home/investitsii/item/2298-uchenyj-izobretatel-biznesmen
8. Pages: 102-105: https://issuu.com/seatrial/docs/sea_trial_006_2017
9. Pages 104-105: https://issuu.com/seatrial/docs/sea_trial_007_2017/104
10. https://www.youtube.com/watch?v=GnFvkRgKN5o
11. https://www.youtube.com/watch?v=zWzKY3MJbxU&feature=youtu.be
12. http://www.rusmonaco.fr/index.php/item/650
13. http://www.rusmonaco.fr/index.php/item/699
14. http://www.rusmonaco.fr/index.php/item/684